A Watershed Moment in Oncology In the summer of 2026, the oncology world collectively held its breath. The announcement from pharmaceutical giants Moderna and Merck wasn’t just another routine press release; it represented a seismic shift in the decades-long war against cancer. Their personalized mRNA vaccine, scientifically designated as intismeran autogene, had accomplished what no mRNA therapy had ever achieved before: it succeeded in a massive, late-stage (Phase 3) clinical trial. For patients battling high-risk melanoma—the deadliest form of skin cancer—this vaccine, when combined with the established immunotherapy drug Keytruda, dramatically reduced the likelihood of the cancer returning. This wasn’t…

It is the height of summer, yet the ground beneath our feet is already crunching with fallen leaves. A walk through the park in late August feels deeply disorienting, like stepping into a season that has arrived months too early. This unsettling phenomenon, aptly dubbed a “false autumn,” is sweeping across the United Kingdom, and it is turning our green spaces into startling shades of brown and amber. The culprit is not a premature calendar shift but the relentless, record-breaking heatwave and drought that have gripped the nation. Trees, in a desperate act of self-preservation, are shutting down their leafy…